Crossmark

Delay in antibiotic therapy results in fatal disease outcome in murine pneumococcal pneumonia

Crossref DOI link: https://doi.org/10.1186/s13054-018-2224-5

Published Online: 2018-11-01

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Berger, Sarah

Goekeri, Cengiz

Gupta, Shishir K.

Vera, Julio

Dietert, Kristina

Behrendt, Ulrike

Lienau, Jasmin

Wienhold, Sandra-Maria

Gruber, Achim D.

Suttorp, Norbert

Witzenrath, Martin

Nouailles, Geraldine https://orcid.org/0000-0003-1973-3119
Funding

Funding for this research was provided by:

Bundesministerium für Bildung und Forschung (01ZX1304B)

Bundesministerium für Bildung und Forschung (01ZX1304B)

Bundesministerium für Bildung und Forschung (01ZX1604B)

Bundesministerium für Bildung und Forschung (01ZX1604B)

Bundesministerium für Bildung und Forschung (01ZX1304F)

Bundesministerium für Bildung und Forschung (01ZX1604F)

Deutsche Forschungsgemeinschaft (SFB-TR84 project B1)

Deutsche Forschungsgemeinschaft (SFB-TR84 project C3/C6/C9)

Deutsche Forschungsgemeinschaft (SFB-TR84 project Z1b)
License Information

Text and Data Mining valid from 2018-11-01
More Information

Article History

Received: 8 June 2018

Accepted: 9 October 2018

First Online: 1 November 2018

Ethics approval and consent to participate

: All animal procedures were approved by local institutional (Charité — Universitätsmedizin Berlin) and governmental (Landesamt für Gesundheit und Soziales (LaGeSo) Berlin) authorities.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.